ReviewPublished 12 October 2026Glutamine metabolic reprogramming in acute and chronic kidney diseases: mechanistic insights and therapeutic implicationsRuotong Xu · Jin Zhao · Minna Liu · Yifan Qiao · Xiaoxuan Ning · Shiren SunFrontiers in Immunologydoi 10.3389/fimmu.2026.1939528
EditorialPublished 18 August 2026Editorial: Targeting cancer metabolic reprogramming for cancer therapyWerner J. Geldenhuys · Haitao M. Ji · Hoang V. LeFrontiers in Drug Discoverydoi 10.3389/fddsv.2026.1916506